CRISPR vs breast, colon and lung cancer: first-in-human trial going well
Share on PinterestIn a small trial, researchers have used gene-editing technology for the first time to treat breast, colon and lung cancer in humans. Image credit: Andrew Brookes/Getty Images. For the first time, researchers have used CRISPR technology to substitute genes in patients’ immune cells to treat cancer. Participants included 16 patients with different solid …
CRISPR vs breast, colon and lung cancer: first-in-human trial going well Read More »